Adenosine deaminases acting on RNA (ADARs) are zinc-containing enzymes that deaminate adenosine bases to inosines within dsRNA regions in transcripts. In short, structured dsRNA hairpins individual adenosine bases may be targeted specifically and edited with up to one hundred percent efficiency, leading to the production of alternative protein variants. However, the majority of editing events occur within longer stretches of dsRNA formed by pairing of repetitive sequences. Here, many different adenosine bases are potential targets but editing efficiency is usually much lower. Recent work shows that ADAR-mediated RNA editing is also required to prevent aberrant activation of antiviral innate immune sensors that detect viral dsRNA in the cytoplasm. Missense mutations in the ADAR1 RNA editing enzyme cause a fatal auto-inflammatory disease, Aicardi-Goutières syndrome (AGS) in affected children. In addition RNA editing by ADARs has been observed to increase in many cancers and also can contribute to vascular disease. Thus the role of RNA editing in the progression of various diseases can no longer be ignored. The ability of ADARs to alter the sequence of RNAs has also been used to artificially target model RNAs in vitro and in cells for RNA editing. Potentially this approach may be used to repair genetic defects and to alter genetic information at the RNA level. In this review we focus on the role of ADARs in disease development and progression and on their potential use to artificially modify RNAs in a targeted manner.

b CEITEC at Masaryk University Kamenice Czech Republic

Medical University of Vienna Center of Anatomy and Cell Biology Department of Cell and Developmental Biology Schwarzspanierstrasse Vienna Austria

See more in PubMed

Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012; 13:227-32; PMID:22411467; http://dx.doi.org/10.1038/nrg3185 PubMed DOI PMC

Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. Cell 2015; 161:1388-99; PMID:26046440; http://dx.doi.org/10.1016/j.cell.2015.05.014 PubMed DOI PMC

Behm-Ansmant I, Helm M, Motorin Y. Use of specific chemical reagents for detection of modified nucleotides in RNA. J Nucleic Acids 2011; 2011:408053; PMID:21716696; http://dx.doi.org/10.4061/2011/408053 PubMed DOI PMC

Machnicka MA, Milanowska K, Osman Oglou O, Purta E, Kurkowska M, Olchowik A, Januszewski W, Kalinowski S, Dunin-Horkawicz S, Rother KM, et al.. MODOMICS: a database of RNA modification pathways–2013 update. Nucleic Acids Res 2013; 41:D262-7; PMID:23118484; http://dx.doi.org/10.1093/nar/gks1007 PubMed DOI PMC

Bass BL, Nishikura K, Keller W, Seeburg PH, Emeson RB, O'Connell MA, Samuel CE, Herbert A. A standardized nomenclature for adenosine deaminases that act on RNA. RNA 1997; 3:947-9; PMID:9292492 PubMed PMC

Higuchi M, Single FN, Kohler M, Sommer B, Sprengel R, Seeburg PH. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 1993; 75:1361-70; PMID:8269514; http://dx.doi.org/10.1016/0092-8674(93)90622-W PubMed DOI

Ryman K, Fong N, Bratt E, Bentley DL, Ohman M. The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript. Rna 2007; 13:1071-8; PMID:17525170; http://dx.doi.org/10.1261/rna.404407 PubMed DOI PMC

Gerber AP, Keller W. RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem Sci 2001; 26:376-84; PMID:11406411; http://dx.doi.org/10.1016/S0968-0004(01)01827-8 PubMed DOI

St Johnston D, Brown NH, Gall JG, Jantsch M. A conserved double-stranded RNA-binding domain. Proc Natl Acad Sci USA 1992; 89:10979-83 PubMed PMC

Wang C, Xu JR, Liu H. A-to-I RNA editing independent of ADARs in filamentous fungi. RNA Biol 2016; 13:940-5; http://dx.doi.org/10.1080/15476286.2016.1215796 PubMed DOI PMC

Schumacher JM, Lee K, Edelhoff S, Braun RE. Distribution of Tenr, an RNA-binding protein, in a lattice-like network within the spermatid nucleus in the mouse. Biol Reprod 1995; 52:1274-83; PMID:7543294 PubMed

Kim U, Wang Y, Sanford T, Zeng Y, Nishikura K. Molecular cloning of cDNAs for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci USA 1994; 91:11457-61; PMID:7972084 PubMed PMC

O'Connell MA, Krause S, Higuchi M, Hsuan JJ, Totty NF, Jenny A, Keller W. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol Cell Biol 1995; 15:1389-97; PMID:7862132 PubMed PMC

Patterson JB, Samuel CE. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol 1995; 15:5376-88 PubMed PMC

Strehblow A, Hallegger M, Jantsch MF. Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol Biol Cell 2002; 13:3822-35; PMID:12429827; http://dx.doi.org/10.1091/mbc.E02-03-0161 PubMed DOI PMC

Herbert A, Schade M, Lowenhaupt K, Alfken J, Schwartz T, Shlyakhtenko LS, Lyubchenko YL, Rich A. The Zalpha domain from human ADAR1 binds to the Z-DNA conformer of many different sequences. Nucleic Acids Res 1998; 26:3486-93; PMID:9671809 PubMed PMC

Melcher T, Maas S, Higuchi M, Keller W, Seeburg PH. Editing of AMPA receptor GluR-B pre-mRNA in vitro reveals site-selective adenosine to inosine conversion. J Biol Chem 1995; 270:8566-70; PMID:7721757; http://dx.doi.org/10.1074/jbc.270.15.8566 PubMed DOI

Melcher T, Maas S, Herb A, Sprengel R, Higuchi M, Seeburg PH. RED2, a brain specific member of the RNA-specific adenosine deaminase family. J Biol Chem 1996; 271:31795-8 PubMed

Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. Rna 2000; 6:755-67; PMID:10836796 PubMed PMC

Connolly CM, Dearth AT, Braun RE. Disruption of murine Tenr results in teratospermia and male infertility. Dev Biol 2005; 278:13-21; PMID:15649457; http://dx.doi.org/10.1016/j.ydbio.2004.10.009 PubMed DOI

Matthews MM, Thomas JM, Zheng Y, Tran K, Phelps KJ, Scott AI, Havel J, Fisher AJ, Beal PA. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat Struct Mol Biol 2016; 23:426-33; PMID:27065196; http://dx.doi.org/10.1038/nsmb.3203 PubMed DOI PMC

Bass BL, Weintraub H, Cattaneo R, Billeter MA. Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell 1989; 56:331. PubMed

Ramaswami G, Zhang R, Piskol R, Keegan LP, Deng P, O'Connell MA, Li JB. Identifying RNA editing sites using RNA sequencing data alone. Nat Methods 2013; 10:128-32; PMID:23291724; http://dx.doi.org/10.1038/nmeth.2330 PubMed DOI PMC

Bazak L, Haviv A, Barak M, Jacob-Hirsch J, Deng P, Zhang R, Isaacs FJ, Rechavi G, Li JB, Eisenberg E, et al.. A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes. Genome Res 2014; 24:365-76; PMID:24347612; http://dx.doi.org/10.1101/gr.164749.113 PubMed DOI PMC

Lehmann KA, Bass BL. The importance of internal loops within RNA substrates of ADAR1. J Mol Biol 1999; 291:1-13 PubMed

Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, et al.. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 2004; 22:1001-5; PMID:15258596; http://dx.doi.org/10.1038/nbt996 PubMed DOI

Neeman Y, Levanon EY, Jantsch MF, Eisenberg E. RNA editing level in the mouse is determined by the genomic repeat repertoire. RNA 2006; 12:1802-9; PMID:16940548;; http://dx.doi.org/10.1261/rna.165106 PubMed DOI PMC

Pinto Y, Cohen H, Levanon E. Mammalian conserved ADAR targets comprise only a small fragment of the human editosome. Genome Biol 2014; 15:R5. PubMed PMC

Daniel C, Silberberg G, Behm M, Ohman M. Alu elements shape the primate transcriptome by cis-regulation of RNA editing. Genome Biol 2014; 15:R28. PubMed PMC

Alon S, Garrett SC, Levanon EY, Olson S, Graveley BR, Rosenthal JJ, Eisenberg E. The majority of transcripts in the squid nervous system are extensively recoded by A-to-I RNA editing. eLife 2015; 4; PMID:25569156; http://dx.doi.org/10.7554/eLife.05198 PubMed DOI PMC

Mannion N, Arieti F, Gallo A, Keegan LP, O'Connell MA. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins. Biomolecules 2015; 5:2338-62; PMID:26437436; http://dx.doi.org/10.3390/biom5042338 PubMed DOI PMC

Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 2009; 79:321-49 PubMed PMC

Paro S, Li X, O'Connell MA, Keegan LP. Regulation and functions of ADAR in Drosophila. Current Topics in Microbiology and Immunology 2012; 353:221-36; PMID:21761288; http://dx.doi.org/10.1007/82_2011_152 PubMed DOI

Li JB, Levanon EY, Yoon JK, Aach J, Xie B, Leproust E, Zhang K, Gao Y, Church GM. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009; 324:1210-3; PMID:19478186; http://dx.doi.org/10.1126/science.1170995 PubMed DOI

Rueter SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999; 399:75-80 PubMed

Ferreira PG, Oti M, Barann M, Wieland T, Ezquina S, Friedlander MR, Rivas MA, Esteve-Codina A, GEUVADIS Consortium, Rosenstiel P, Strom TM, et al.. Sequence variation between 462 human individuals fine-tunes functional sites of RNA processing. Sci Rep 2016; 6:32406; PMID:27617755; http://dx.doi.org/10.1038/srep32406 PubMed DOI PMC

Casey JL. RNA editing in hepatitis delta virus. Curr Top Microbiol Immunol 2006; 307:67-89; PMID:16903221 PubMed

Casey JL, Gerin JL. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol 1995; 69:7593-600 PubMed PMC

Polson AG, Bass BL, Casey JL. RNA editing of hepatitis delta antigenome by dsRNA-adenosine deaminase. Nature (London) 1996; 380:454-6; PMID:8602246; http://dx.doi.org/10.1038/380454a0 PubMed DOI

Feng Y, Sansam CL, Singh M, Emeson RB. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol Cell Biol 2006; 26:480-8; PMID:16382140; http://dx.doi.org/10.1128/MCB.26.2.480-488.2006 PubMed DOI PMC

Sommer B, Kohler M, Sprengel R, Seeburg PH. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 1991; 67:11-9 PubMed

Burnashev N, Monyer H, Seeburg PH, Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 1992; 8:189-98; PMID:1370372 PubMed

Brusa R, Zimmermann F, Koh DS, Feldmeyer D, Gass P, Seeburg PH, Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995; 270:1677-80; PMID:750208 PubMed

Higuchi M, Maas S, Single F, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000; 406:78-81 PubMed

Schoft VK, Schopoff S, Jantsch MF. Regulation of glutamate receptor B pre-mRNA splicing by RNA editing. Nucleic Acids Res 2007; 35:3723-32; PMID:17517775 PubMed PMC

Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004; 427:801. PubMed

Veno M, Bramsen JB, Bendixen C, Panitz F, Holm I, Ohman M, Kjems J. Spatio-temporal regulation of ADAR editing during development in porcine neural tissues. RNA biology 2012; 9:1054-65; PMID:22858680; http://dx.doi.org/10.4161/rna.21082 PubMed DOI PMC

Ring H, Boije H, Daniel C, Ohlson J, Ohman M, Hallbook F. Increased A-to-I RNA editing of the transcript for GABAA receptor subunit alpha3 during chick retinal development. Vis Neurosci 2010; 27:149-57 PubMed

Daniel C, Wahlstedt H, Ohlson J, Bjork P, Ohman M. A-to-I RNA editing affects trafficking of the {gamma}-aminobutyric acid type A (GABAA) receptor. J Biol Chem 2010 PubMed PMC

Bercovich Z, Kahana C. Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme. J Biol Chem 2004; 279:54097-102; PMID:15491992; http://dx.doi.org/10.1074/jbc.M410234200 PubMed DOI

Kahana C. Antizyme and antizyme inhibitor, a regulatory tango. Cell Mol Life Sci 2009; 66:2479-88 PubMed PMC

Newman RM, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M, Finley D, Zetter BR. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem 2004; 279:41504-11; PMID:15277517; http://dx.doi.org/10.1074/jbc.M407349200 PubMed DOI

Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, et al.. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 2013; 19:209-16 PubMed PMC

Stellos K, Gatsiou A, Stamatelopoulos K, Perisic Matic L, John D, Lunella FF, Jaé N, Rossbach O, Amrhein C, Sigala F, et al.. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation. Nat Med 2016; 22:1140-50; PMID:27595325; http://dx.doi.org/10.1038/nm.4172 PubMed DOI

Shi GP, Sukhova GK, Kuzuya M, Ye Q, Du J, Zhang Y, Pan JH, Lu ML, Cheng XW, Iguchi A, et al.. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ Res 2003; 92:493-500; PMID:12600886;http://dx.doi.org/10.1161/01.RES.0000060485.20318.96 PubMed DOI

Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kalluri R, Shi GP. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 2006; 281:6020-9 PubMed

Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 1998; 101:2351-63; PMID:9616206 PubMed PMC

Reiser J, Adair B, Reinheckel T. Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 2010; 120:3421-31; PMID:20921628; http://dx.doi.org/10.1172/JCI42918 PubMed DOI PMC

Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L, Di Rocco C, O'Connell MA, Gallo A. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem 2008; 283:7251-60; PMID:18178553; http://dx.doi.org/10.1074/jbc.M708316200 PubMed DOI

Maas S, Patt S, Schrey M, Rich A. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A 2001; 98:14687-92 PubMed PMC

Jiang Q, Crews LA, Barrett CL, Chun HJ, Court AC, Isquith JM, Zipeto MA, Goff DJ, Minden M, Sadarangani A, et al.. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc Natl Acad Sci U S A 2013; 110:1041-6; PMID:23275297; http://dx.doi.org/10.1073/pnas.1213021110 PubMed DOI PMC

Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E, Levanon EY. Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors. Cell Rep 2015; 13:267-76; PMID:26440895; http://dx.doi.org/10.1016/j.celrep.2015.08.080 PubMed DOI

Han L, Diao L, Yu S, Xu X, Li J, Zhang R, Yang Y, Werner HM, Eterovic AK, Yuan Y, et al.. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer Cell 2015; 28:515-28; PMID:26439496; http://dx.doi.org/10.1016/j.ccell.2015.08.013 PubMed DOI PMC

Fumagalli D, Gacquer D, Rothe F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, et al.. Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome. Cell reports 2015; 13:277-89 PubMed PMC

Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, et al.. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell 2016; 164:1073; PMID:27064190; http://dx.doi.org/10.1016/j.cell.2015.10.020 PubMed DOI

Cattaneo R, Kaelin K, Baczko K, Billeter MA. Measles virus editing provides an additional cysteine-rich protein. Cell 1989; 56:759-64; PMID:2924348 PubMed

Cattaneo R, Schmid A, Eschle D, Baczko K, ter Meulen V, Billeter MA. Biased hypermuation and other genetic changes in defective measles viruses in human brain infections. Cell 1988; 55:255-65; PMID:3167982 PubMed PMC

Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011; 411:180-93 PubMed PMC

Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem 2004; 279:4952-61; PMID:14613934; http://dx.doi.org/10.1074/jbc.M310162200 PubMed DOI

Hartner JC, Schmittwolf C, Kispert A, Muller AM, Higuchi M, Seeburg PH. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem 2004; 279:4894-902 PubMed

Zhang XJ, He PP, Li M, He CD, Yan KL, Cui Y, Yang S, Zhang KY, Gao M, Chen JJ, et al.. Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH). Hum Mutat 2004; 23:629-30; PMID:15146470; http://dx.doi.org/10.1002/humu.9246 PubMed DOI

Tojo K, Sekijima Y, Suzuki T, Suzuki N, Tomita Y, Yoshida K, Hashimoto T, Ikeda S. Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Mov Disord 2006; 21:1510-3 PubMed

Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, et al.. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genetics 2012; 44:1243-8; PMID:23001123; http://dx.doi.org/10.1038/ng.2414 PubMed DOI PMC

Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20 PubMed

Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730-7; PMID:15208624; http://dx.doi.org/10.1038/ni1087 PubMed DOI

Kang DC, Gopalkrishnan RV, Wu Q, Jankowsky E, Pyle AM, Fisher PB. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U S A 2002; 99:637-42; PMID:11805321; http://dx.doi.org/10.1073/pnas.022637199 PubMed DOI PMC

Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2010; 107:1512-7; PMID:20080593; http://dx.doi.org/10.1073/pnas.0912986107 PubMed DOI PMC

Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W, Coch C, Janke M, Mihailovic A, Wardle G, et al.. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009; 31:25-34; PMID:19576794; http://dx.doi.org/10.1016/j.immuni.2009.05.008 PubMed DOI PMC

Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, Chu F, Walz T, Hur S. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013; 152:276-89; PMID:23273991; http://dx.doi.org/10.1016/j.cell.2012.11.048 PubMed DOI

Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, et al.. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101-5; PMID:16625202 PubMed

Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, et al.. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008; 82:335-45; PMID:17942531 PubMed PMC

Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011; 147:423-35; PMID:22000019; http://dx.doi.org/10.1016/j.cell.2011.09.039 PubMed DOI

Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. Structural insights into RNA recognition by RIG-I. Cell 2011; 147:409-22; PMID:22000018; http://dx.doi.org/10.1016/j.cell.2011.09.023 PubMed DOI PMC

Cai X, Chen J, Xu H, Liu S, Jiang QX, Halfmann R, Chen ZJ. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014; 156:1207-22; PMID:24630723; http://dx.doi.org/10.1016/j.cell.2014.01.063 PubMed DOI PMC

Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellåker C, Vesely C, Ponting CP, McLaughlin PJ, et al.. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell reports 2014; 9:1482-94; PMID:25456137; http://dx.doi.org/10.1016/j.celrep.2014.10.041 PubMed DOI PMC

Pestal K, Funk CC, Snyder JM, Price ND, Treuting PM, Stetson DB. Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development. Immunity 2015; 43:933-44; PMID:26588779; http://dx.doi.org/10.1016/j.immuni.2015.11.001 PubMed DOI PMC

Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, Li JB, Seeburg PH, Walkley CR. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 2015; 349:1115-20; PMID:26275108; http://dx.doi.org/10.1126/science.aac7049 PubMed DOI PMC

Liddicoat BJ, Chalk AM, Walkley CR. ADAR1, inosine and the immune sensing system: distinguishing self from non-self. Wiley Interdiscip Rev RNA 2016; 7:157-72; PMID:26692549; http://dx.doi.org/10.1002/wrna.1322 PubMed DOI

Barrangou R, Doudna JA. Applications of CRISPR technologies in research and beyond. Nat Biotechnol 2016; 34:933-41; PMID:27606440; http://dx.doi.org/10.1038/nbt.3659 PubMed DOI

Montiel-Gonzalez MF, Vallecillo-Viejo I, Yudowski GA, Rosenthal JJ. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci U S A 2013; 110:18285-90; PMID:24108353; http://dx.doi.org/10.1073/pnas.1306243110 PubMed DOI PMC

Montiel-Gonzalez MF, Vallecillo-Viejo IC, Rosenthal JJ. An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res 2016; 44:e157; PMID:27557710; http://dx.doi.org/10.1093/nar/gkw738 PubMed DOI PMC

Stafforst T, Schneider MF. An RNA-deaminase conjugate selectively repairs point mutations. Angew Chem Int Ed Engl 2012; 51:11166-9; PMID:23038402; http://dx.doi.org/10.1002/anie.201206489 PubMed DOI

Vogel P, Schneider MF, Wettengel J, Stafforst T. Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA. Angew Chem Int Ed Engl 2014; 53:6267-71; PMID:24890431; http://dx.doi.org/10.1002/anie.201402634 PubMed DOI

Hanswillemenke A, Kuzdere T, Vogel P, Jekely G, Stafforst T. Site-Directed RNA Editing in Vivo Can Be Triggered by the Light-Driven Assembly of an Artificial Riboprotein. J Am Chem Soc 2015; 137:15875-81; PMID:26594902; http://dx.doi.org/10.1021/jacs.5b10216 PubMed DOI PMC

Wettengel J, Reautschnig P, Geisler S, Kahle PJ, Stafforst T. Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res 2016; PMID:27907896; http://dx.doi.org/10.1093/nar/gkw911 PubMed DOI PMC

Heep M, Mach P, Reautschnig P, Wettengel J, Stafforst T. Applying Human ADAR1p110 and ADAR1p150 for Site-Directed RNA Editing-G/C Substitution Stabilizes GuideRNAs against Editing. Genes (Basel) 2017; 8:E34; PMID:28098820; http://dx.doi.org/10.3390/genes8010034 PubMed DOI PMC

Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M, Hershkovitz V, Peer E, Mor N, Manor YS, et al.. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 2015; 347:1002-6; PMID:25569111; http://dx.doi.org/10.1126/science.1261417 PubMed DOI

Dominissini D, Nachtergaele S, Moshitch-Moshkovitz S, Peer E, Kol N, Ben-Haim MS, Dai Q, Di Segni A, Salmon-Divon M, Clark WC, et al.. The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA. Nature 2016; 530:441-6; PMID:26863196; http://dx.doi.org/10.1038/nature16998 PubMed DOI PMC

Vaidyanathan PP, AlSadhan I, Merriman DK, Al-Hashimi H, Herschlag D. Pseudouridine and N-6 methyladenosine modifications weaken PUF protein/RNA interactions. RNA 2017; PMID:28138061; http://dx.doi.org/10.1261/rna.060053.116 PubMed DOI PMC

Karijolich J, Yu YT. Converting nonsense codons into sense codons by targeted pseudouridylation. Nature 2011; 474:395-8; PMID:21677757; http://dx.doi.org/10.1038/nature10165 PubMed DOI PMC